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Graphical contents entry 
The accumulation of targeted drug carriers in the diseased 
tissue is substantially affected by the locally acting 
hydrodynamic drag forces. A thumbnail-sized microfluidic 
chip incorporating a surface acoustic wave pump can be 
used to study the adhesion of particles to cells under physiological flow conditions.  
 
 
Summary 
The interaction of targeted drug carriers with epithelial and endothelial barriers in vivo is 
largely determined by the dynamics of the body fluids. To simulate these conditions in 
binding assays, a fully biocompatible in vitro model was developed which can accurately 
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mimic a wide range of physiological flow conditions on a thumbnail-format cell-chip. This 
acoustically-driven microfluidic system was used to study the interaction characteristics of 
protein-coated particles with cells. Poly(D,L-lactide-co-glycolide) (PLGA) microparticles 
(2.86 ± 0.95 µm) were conjugated with wheat germ agglutinin (WGA-MP, cytoadhesive 
protein) or bovine serum albumin (BSA-MP, nonspecific protein) and their binding to 
epithelial cell monolayers was investigated under stationary and flow conditions. While mean 
numbers of 1500 ± 307 mm-2 WGA-MP and 94 ± 64 mm-2 BSA-MP respectively were 
detected to be cell-bound in the stationary setup, incubation at increasing flow velocities 
increasingly antagonized the attachment of both types of surface-modified particles. However, 
while binding of BSA-MP was totally inhibited by flow, grafting with WGA resulted in a 
pronounced anchoring effect. This was indicated by a mean number of 747 ± 241 mm-2 and 
104 ± 44 mm-2 attached particles at shear rates of 0.2 s-1 and 1 s-1 respectively. Due to the 
compactness of the fluidic chip which favours parallelization, this setup represents a highly 
promising approach towards a screening platform for the performance of drug delivery 
vehicles under physiological flow conditions. In this regard, the flow-chip is expected to 
provide substantial information for the successful design and development of targeted micro- 
and nanoparticulate drug carrier systems.  
 
Introduction 
Physiological and pathological processes such as the site-specific adhesion of platelets, 
leukocytes or metastasizing cancer cells underlie sophisticated mechanisms in order to 
efficiently function in the presence of hydrodynamic flow. Substantial knowledge about these 
processes has been generated by simulating physiological shear conditions with in vitro 
fluidic systems such as the parallel plate flow chamber (PPFC) and the radial flow detachment 
assay (RFDA).[1-4] Although primarily aimed at understanding physiology, these fundamental 
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studies also bear essential implications for the development of targeted colloidal drug 
carriers.[1, 3, 5] Presently, the target effect of site-specific drug delivery systems is by default 
determined with in vitro cell binding assays under stationary conditions. However, regarding 
the extent and specificity of particle binding, recent reports have identified clear discrepancies 
between the results obtained from stationary and more realistic, dynamic models of the in vivo 
environment.[6-8] Particularly, the presence of substantial hydrodynamic drag forces upon 
application in vivo is expected to explicitly affect the deposition characteristics of ligand-
coated particles.[7, 9, 10] The peristaltic motion in the gastrointestinal tract, for example, leads 
to streaming velocities of ~85 µm s-1 in the jejunum and ~55 µm s-1 in the ileum.[11] The 
variation of flow conditions in the circulatory system is even more pronounced as illustrated 
by effective shear rates ranging from 1 s-1 in wide vessels to 105 s-1 in small arteries.[12] To 
attain preferential binding of the carrier to the diseased tissue in this environment, the size and 
ligand coating density of the colloids has to be adjusted according to the flow conditions as 
well as the expected receptor density and affinity at the target tissue.[1, 2, 5]  In order to be able 
to practically optimize these parameters of potential drug delivery vehicles, parallelisable in 
vitro bioassays have to be developed which offer the possibility of controllable flow 
generation. At this, increased experimental throughput is highly necessary in order to cope 
with the extensive amount of samples which have to be processed to generate sufficient data 
sets. Although well suited for specific questions, the PPFC and RFDA are of limited use for 
such applications. When multiple experiments are demanded at high reproducibility, the 
complexity of these methods’ tubing and chambers becomes cumbersome to handle. 
Microfluidic pumping techniques might allow for approaching these shortcomings 
successfully. The most common methods to generate flow in miniaturised systems are 
thermophoresis (via Marangoni forces), electrochemical reactions, surface patterning 
methods, electro-osmosis, induced charge electro-osmosis as well as several mechanical 
pumping strategies.[13, 14] However, these techniques’ suitability is limited for systems which 
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are required to comply with cell growth and cell viability. For such applications a 
micropumping technology based on acoustic streaming might represent a highly promising 
alternative. This technique generates locally defined surface acoustic waves (SAWs) which, 
when coupled into liquid, result in a defined pressure gradient that can be utilized for 
streaming (Figure 1A).  
 
 
Figure 1. SAWs are generated on a piezoelectric chip and lead to fluid streaming with a parabolic flow profile 
when coupled into a liquid-filled channel (A). Dimensions of the SAW-chip with a positioned 3D-microchannel 
(B). Cross section of the flow velocity profile generated in a 3D-microchannel by acoustic streaming 4 mm x 3 
mm (width x height) (C). Horizontal (D, solid line) and vertical cut (D, dashed line) through (C).  
 
 
In the work presented, the applicability of this technology to controllably produce fluid flow 
in a miniaturized pharmaceutically relevant in vitro bioassay was tested. At this, the effect of 
shearing on the association of protein-decorated particles with epithelial cell monolayers was 
investigated. Biocompatible poly(D,L-lactide-co-glycolide) (PLGA) microparticles (MP) 
conjugated with fluorescence labelled wheat germ agglutinin (WGA) and bovine serum 
albumin (BSA) served as representative targeted and non-targeted model drug carrier systems. 
This model system was chosen, since studies have shown that decoration with WGA mediates 
binding to Caco-2 cells under stationary conditions.[15, 16] The extent of a targeting effect in 
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the presence of hydrodynamic drag was investigated using the micropumping SAW-chip 
(Figure 1B) to simulate physiological flow conditions.  
 
Results and discussion 
The acoustically-driven microfluidic system 
Similar to conventional flow assays such as the PPFC and RFDA, the acoustically-driven 
flow chip is based on a fluidic channel which is directly accessible during the experiment via 
microscopy. However, in contrast to the previously mentioned assays that are driven by 
external mechanical pumps, the developed microfluidic chip uses a planar, non invasive 
pumping principle for flow generation. This technique realizes the contamination-free 
pumping of liquid volumes as small as a few microliters by surface acoustic streaming which 
can generate shear rates between 0.01 s-1 and 1000 s-1 depending on the system’s geometry. 
As a consequence of the high frequency signal based generation of the SAW, the pumping 
performance is continuously actuated and varied via the parameters of a conventional signal 
generator (see Video S1 of the Supporting Information).[17] By channelizing the streamed 
liquid into 3D-microchannels, which are readily fabricated in almost arbitrary geometries by 
elastomeric molding, a flow chamber can be created. In this study, a rather simple 44 mm x 4 
mm x 3 mm (length x width x height) racetrack-format poly(dimethylsiloxane) (PDMS)-cast 
was used (Figure 1B). The channel was dimensioned in such a manner that sufficient medium 
could be included for uncomplicated cell culturing of epithelial Caco-2 monolayers. Thus, the 
usually necessary transfer of a cell-covered substrate to the flow chamber or alignment of an 
elastomeric cast on the cultured cells can be avoided. However, the pumping technique is not 
limited to rectangular casts of this size, but can be easily adapted to drive flow in smaller 
structures with constrictions or bifurcations.[17] Channels including the latter geometries could 
be exceptionally insightful tools for a realistic simulation of the complex vessel-flow in the 
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circulatory system.[9] At this, it is additionally helpful, that not only continuous flow modes 
can be accurately mimicked on the SAW-chip, but that also precisely defined pulsed pumping 
is possible. While being hardly achievable with mechanical pumps, this streaming mode is 
controllably induced by amplitude modulation of the high frequency signal (see Video S2 of 
the Supporting Information). Thereby, the effects of pulsating flow combined with defined 
shear rates could be collectively investigated regarding their impact on distribution and 
adhesion processes in the branched circulatory system.[9]  
Besides its compliance with microfluidic channels, which allows for reducing the necessary 
amount of reagents to a minimum, the chip-based setup additionally bears the advantage of 
omitting tubing and connectors which are otherwise necessary to pipeline liquid within the 
system. Consequently, the dead volume associated with mechanical pumps is avoidable and 
the entire device can be downsized notably (Figure 1B). This feature is essential, as it permits 
parallelization of several SAW-chips in one platform thus increasing the amount of samples 
which can be processed simultaneously. Even a setup with multiple SAW-pumps and 
channels in a microplate format is realizable, entailing the ability to use microplate readers for 
analysis. Such an extension to more sensitive analytical methods could be a powerful tool to 
gain information on adhesion phenomena involving nanoparticles or proteins, since analyses 
based on microscopic imaging hit on their limits in this size regime.  
Cell-binding of surface-modified microparticles under stationary conditions 
To establish reference values for the experiments involving fluid flow, the extent of binding 
of BSA- and WGA-MP to Caco-2 monolayers was primarily determined in a stationary setup 
(flow velocitymax = 0 µm s-1). For the used microparticles with a mean size of 2.86 ± 0.95 µm 
and a density of ~ 1.28 g cm-3 a sedimentation controlled particle deposition is expected.[18] In 
the equilibrium state between frictional force and gravitation, settling of the colloids occurs 
with a constant z-velocity of 1.4 µm s-1. Consequently, 83% of the homogenously distributed 
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particles are assumed to deposit on the surface within 30 min leading to a maximum coverage 
of 3500 mm-2. In practice, however, only 94 ± 64 mm-2 BSA-MP were detected after 
stationary loading (30 min), washing and stationary chase-incubation (30 min) (Figure 2, 
stars). The rather low number of cell-associated particles, which corresponds to 3% of the  
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Figure 2. Mean number of WGA- (squares) and BSA-MP (stars) associated with Caco-2 monolayers after 
loading for 30 min at stationary conditions, washing and chase-incubation under stationary or flow conditions. 
Each set of data points was obtained from independent experimental series. 
 
theoretical load, can be explained by the reportedly low affinity of albumin-coated PLGA-
particles to Caco-2 cells.[6, 15] Due to the lack of interactive strength the washing steps resulted 
in the detachment of all except a few non-specifically bound particles. In contrast, 
conjugation with f-WGA led to a clearly enhanced adhesion of colloids to the monolayer. 
This is in line with previous studies which have identified WGA as an agent for enhancing 
adhesion to Caco-2 cells.[19, 20] Following incubation under stationary conditions a mean 
number of 1500 ± 307 mm-2 cell-associated particles, which corresponds to 43% of the 
maximum load, were detected. This 16-fold increased interaction as compared to BSA-MP is 
explicitly illustrated in Figure 3 and can be attributed to specific binding of the lectin to  
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 Figure 3. Cell-associated WGA-MP (A) and BSA-MP (C) respectively after loading for 30 min, washing and 
chase-incubation under stationary conditions (flow velocitymax = 0 µm s-1). Chase-incubation performed under 
flow conditions (flow velocitymax = 1700 µm s-1; B and D respectively). Microparticles (green) and tight junction 
associated protein ZO-1 (red). Bar represents 20 µm.  
 
membrane-associated N-acetyl-D-glucosamine and N-acetyl-neuraminic-acid residues.[15, 21] 
WGA-MP which had not bound to the cell membrane were removed in course of the washing 
steps.  
Impact of flow on cell-bound particles 
To investigate the effect of different shear rates on cell-associated BSA- and WGA-MP, 
stationary particle-loaded Caco-2 monolayers were chase-incubated under flow conditions. At 
this, acoustic streaming induces laminar fluid flow in the channel and thereby generates 
hydrodynamic forces acting on the attached microparticles. If the adhesive bonds break and 
do not re-establish elsewhere, the fluid flow transports the colloids to the coupling region of 
the SAW, where the considerable lift forces redisperse them in the channel cross-section. 
Consequently, most of these particles are not available for reattachment to the cells. Using 
this setup, a shear rate dependent reduction of the number of cell-bound particles was 
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monitored for both types of surface-modified colloids (Figure 2). While low shear rates (flow 
velocitymax = 300 µm s-1 and 800 µm s-1) led to the detachment of ~30% and 50% respectively 
of the initially cell-associated BSA-MP, incubation at higher shear rates (flow velocitymax = 
1200 µm s-1 and 1700 µm s-1) almost completely removed the albumin-conjugated colloids 
from the cell-surface (Figure 3D). Obviously, the few BSA-MP, which were associated with 
the Caco-2 monolayer after stationary loading and washing, are characterized by low 
adhesivity which is not sufficient to anchor the particles in the presence of shear forces. In 
contrast, conjugation of microparticles with carbohydrate-binding protein not only led to 
higher cell-binding under stationary conditions but also enhanced retention on the Caco-2 
monolayer in the presence of flow (Figure 2, squares). This is illustrated by a mean number of 
1057 ± 351 mm-2 and 400 ± 168 mm-2 monolayer-associated colloids at the lowest and highest 
flow velocity studied. Consequently, as compared with BSA-MP, WGA-MP were 
characterized by at least 17-fold increased retention over the whole range of flow velocities 
investigated. Interestingly, in case of the highest shear rates, the effect of the lectin-corona 
was even more pronounced as exemplified by 39-fold and 44-fold improved adhesion over 
albumin-conjugated colloids (Figure 3C).  
Regarding reproducibility of the binding assays on the SAW-chip, it should be highlighted 
that the three data series for each particle type plotted in Figure 2 were obtained from separate 
experiments. The low deviation between the curves underlines the SAW-pump’s ability to 
controllably and reproducibly generate flow in the 3D-microchannels, which is a crucial 
prerequisite that determines the practical usability of the system. The standard deviation of 
each data point is comparable with those in similar studies and very likely a result of the 
image-based quantification combined with the cellular substrate inherent characteristics.[7] To 
minimize this, homogenous receptor-coated surfaces could be used, albeit at the cost of 
setting aside the complexly constituted cell membrane. Hence, when probing the interaction 
of targeted drug carriers with biological barriers, a substitution of the cell monolayer by an 
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artificial substrate is not expedient since it reduces the relevance for comparisons with the in 
vivo conditions.[3, 7, 8] When studying isolated adhesion phenomena, however, the 
incorporation of precisely surface-engineered substrates is certainly realisable as well as 
preferable in terms of analytical accuracy.[5, 12, 22]  
Cell-binding of surface-modified microparticles under flow conditions 
Impact of flow on particle deposition in the channel. 
To estimate the effect of flow on the deposition rate of particles in the 3D-microchannels, the 
stationary condition was compared with streaming. The experimental microfluidic setup is 
characterized by Reynolds numbers of Re = 1 and Re = 6 for the lowest and highest velocity 
respectively which indicates laminar flow. As determined by computational fluid dynamics 
simulations the flow profile in the channel is parabolic (Figure 1C, D). Considering these 
conditions and that the images used for quantification of the adherent particles were taken in a 
small central region of the channel, the lateral y-component of the velocity was assumed to be 
widely independent from the vertical z-component. Therefore, a particle’s trajectory in the 
flowing fluid contains components in the direction of flow (x) as well as in the vertical 
direction (z) with the former one depending on the latter. At the start of the experiment, the 
3D-microchannels are filled with buffer containing 7.5 x 105 homogenously distributed 
microparticles which sediment with a constant z-velocity. Upon engaging the flow, these 
particles are travelling for one channel length until again reaching the coupling zone of the 
SAW-pump where they are homogenously redistributed over the cross-section of the channel. 
On each of these rotations, particles below a critical height ǻzcrit settle out on the cell 
monolayer. For a flow velocity vmax of 1700 µm s-1 the critical height ǻzcrit is determined to 
be ~224 µm. Taking into account that the particle density in the channel decreases with 
duration of the experiment, ~56% of the microparticles are expected to have deposited on the 
cell monolayer after 30 min. This corresponds to a theoretical surface coverage of 2400 mm-2. 
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In the case of lower flow velocities the increased critical height ǻzcrit interestingly does not 
lead to a higher deposition rate since its effect is widely levelled out by the proportionally 
lowered particle flux density. Consequently, almost equal particle deposition rates on the cell 
monolayer were to be expected under all investigated flow conditions.  
Binding of BSA- and WGA-MP to a Caco-2 monolayer under flow conditions. 
In order to investigate the binding of BSA- and WGA-MP from a streaming medium to Caco-
2 monolayers, the particle suspension was transferred to the 3D-microchannels and fluid flow 
was instantly engaged. As illustrated in Figure 4 (open symbols), incubation under flow 
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Figure 4. Mean number of WGA-MP (squares) and BSA-MP (stars) associated with Caco-2 monolayers upon 
incubation under stationary and flow conditions. Monolayers pre-loaded with microparticles for 30 min under 
stationary conditions (filled symbols). Direct incubation of microparticles with monolayers under stationary and 
flow conditions (open symbols). 
 
conditions led to a clearly decreased cell binding of the ligand-conjugated colloids. Partially, 
this effect is system inherent and can be attributed to the previously discussed reduction of 
particle deposition due to the parabolic flow in the channel. Taking this into account and 
considering the binding potential of 3% and 43% as determined in the absence of 
hydrodynamic forces, a maximal surface coverage of ~70 mm-2 and ~1000 mm-2 is expected 
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for BSA- and WGA-MP respectively under flow conditions. This estimate seems quite 
realistic as illustrated by 77 ± 31 mm-2 and 747 ± 241 mm-2 respectively bound particles in 
case of the lowest shear force. However, aside from the generally lowered base deposition, the 
number of cell-bound colloids was additionally diminished by the antagonizing effect of flow 
on particle-surface bonds.[4, 5] For BSA-MP this increased hydrodynamic drag resulted in a 
nearly complete inhibition of the association with the Caco-2 monolayer. This is explicated by 
a marginal surface coverage of 34 ± 16 mm-2 cell-associated particles at the highest shear rate. 
Apparently, albumin-modified particles which are deposited on the monolayer under flow 
conditions do not notably interact with the cell membrane. Similar conclusions have been 
described in a recent study where a gas lift driven ussing chamber setup was used to simulate 
the effect of gastrointestinal flow on particle binding.[6] In contrast to albumin-conjugated 
colloids, WGA-MP exhibited higher binding at all investigated flow-conditions. The 
advantage of lectin-conjugation was clearest at low shear rates. However, even at the highest 
flow velocities studied at least threefold more particles associated with the cell monolayer as 
compared with BSA-MP. These observations lead to the conclusion that colloids lacking 
appropriate surface chemistry do not notably attach to Caco-2 cells at relatively moderate 
shear rates ranging from 0.2 s-1 to 1 s-1. When considering this combined with the very low 
cytoadhesion under stationary conditions, the use of BSA-MP as drug carriers is limited. The 
use of plain colloids for most pharmaceutically relevant applications has to be relativized 
even more due to the reportedly marginal cytoadhesion of unconjugated PLGA particles.[15] 
To efficiently compliment the advantageous biocompatibility and biodegradability of particles 
made from PLGA and similar polymers, surface modification with targeting ligands is 
essential. In this regard, however based on stationary studies, wheat germ agglutinin has been 
proposed as a promising candidate to serve this purpose for peroral applications. Due to its 
carbohydrate binding properties, which mediate adhesion to enterocytes as well as mucus, a 
prolonged gastrointestinal residence time of sustained release drug carriers might be 
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achieved.[6, 15, 23] Using the SAW-driven microfluidic device, it was possible to show that the 
interaction between WGA and the Caco-2 cell’s glycocalyx is indeed sufficient to mediate the 
binding of 3µm-sized particles under physiological flow conditions. This observation further 
underlines the potential of wheat germ agglutinin for peroral delivery, where low shear rates 
act on the carrier. However, in the presence of higher flow velocities, the studied WGA-MP 
exhibit a propensity to detach from the cell layer. This could be counteracted by using smaller 
particles, possibly in the nanometer size range, since the effective hydrodynamic drag forces 
decrease with particle diameter.[1] Moreover, conjugation of particles with alternative 
targeting moieties could lead to enhanced cytoadhesion under the shear rates encountered in 
the circulatory system. In this regard, the underlying mechanisms of shear-activated proteinic 
ligands like the FimH subunit of Type-1 fimbriae of E. coli or von Willebrand factor might 
lead the way for the engineering of site-specific drug carriers that efficiently adhere under 
flow conditions.[12, 24] 
 
Experimental  
Materials  
Sylgard® 184 Silicone Elastomer Kit was purchased from Baltres (Baden, Austria). Resomer® 
RG502H (PLGA, lactide/glycolide ratio 50:50, inherent viscosity 0.22 dL g-1, acid number 9 
mg KOH g-1) was obtained from Boehringer Ingelheim (Ingelheim, Germany). Fluorescein-
labeled wheat germ agglutinin (molar ratio fluorescein/protein (F/P) = 2.9) from Triticum 
vulgare was bought from Vector laboratories (Burlingame, USA). FITC-labeled bovine serum 
albumin (F/P = 12), N-(3-Dimethylaminopropyl)-Nƍ-ethylcarbodiimide hydrochloride 
(EDAC), N-hydroxysuccinimide (NHS), and Pluronic® F-68 were purchased from Sigma 
Aldrich (Vienna, Austria). All other chemicals used were of analytical purity. 
Preparation of functionalized microparticles 
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PLGA microparticles with a mean diameter of 2.86 ± 0.95 µm were prepared by spray drying 
of a 6.5% (w/v) solution of PLGA in dichloromethane with a Buechi Mini Spray Dryer B-191 
(Buechi, Flawil, Switzerland) as previously described.[19] For surface modification, 100 mg of 
the PLGA microparticles were suspended in 20 mM HEPES/NaOH pH 7.0 (10 mL) and 
activated with solutions of EDAC (360 mg in 1.5 mL) and NHS (15 mg in 1 mL) in the same 
buffer for 2 h under end-over-end rotation at room temperature. In order to remove excess 
coupling reagent, the suspension was diluted threefold with 20 mM HEPES/NaOH pH 7.4 
and centrifuged (10 min, 2500 rpm, 4°C). The resulting pellet was resuspended in 20 mM 
HEPES/NaOH pH 7.4 (10 mL). Upon addition of F-WGA (1.00 mg) and F-BSA (1.83 mg) 
respectively, end-over-end incubation was performed overnight at room temperature. 
Remaining active ester intermediates were saturated by addition of glycine (450 mg) in 20 
mM HEPES/NaOH pH 7.4 (6 mL) and further incubation for 30 min. Subsequently, the 
microparticles were washed three times by centrifugation (10 min, 3200 rpm, 4°C) and 
resuspension in 20 mM HEPES/NaOH pH 7.4 (30 mL). After the last centrifugation step, the 
particles were suspended in a solution of 0.1% Pluronic F-68 in isotonic 20 mM 
HEPES/NaOH pH 7.4 (10 mL).  
Fabrication of sterile 3D-microchannels  
Base (10 g) and curing agent (1 g) of the silicone elastomer kit were mixed in a test tube, 
vigorously stirred and evacuated for 30min to remove gas bubbles. After pouring the liquid 
prepolymer into pre-structured aluminium molds and hardening over night at 70°C, the 
PDMS replicas were peeled from the master and placed on 24 x 24 mm (length x width) glass 
cover slips. Following assembly, the 3D-microchannels dimensioned 44 x 4 x 3 mm (length x 
width x height) were transferred to glass Petri dishes and autoclaved for 50 min at 121°C (1 
bar). 
Cell Culture in 3D-microchannels 
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The Caco-2 cell line was purchased from the German collection of microorganisms and cell 
culture (DSMZ, Braunschweig, Germany). Tissue culture reagents were obtained from Sigma 
(St. Louis, USA) and Gibco Life Technologies Ltd. (Invitrogen Corp., Carlsbad, USA). Cells 
were cultivated in RPMI 1640 cell-culture medium containing 10% fetal calf serum, 4 mM L-
glutamine and 150 µg mL-1 gentamycine in a humidified 5% CO2/95% air atmosphere at 
37°C and subcultured with Tryple Select from Gibco (Lofer, Austria). For the microfluidic 
experiments, each sterile 3D-microchannel was filled with 500 µL of Caco-2 single cell 
suspension (1.36 x 105 cells mL-1) and cultivated under standard cell culture conditions until a 
confluent cell monolayer had formed. 
Preparation of SAW-chip 
LiNbO3 slides (128°-cut x-propagation) dimensioned 15 x 15 x 0.4 mm (length x width x 
height) were used as piezoelectric substrates. Interdigital metal structures (IDTs) were 
structured on these slides by standard lithographic processes in order to predominately 
generate (Rayleigh-mode) SAWs.[25] The used IDTs had 42 fingerpairs, an aperture of 600 
µm and a periodicity of 26 µm, resulting in a resonance frequency of about 153 MHz. To 
enhance the resistance against mechanical cleaning procedures, the fingers were additionally 
coated with a radio frequency (RF)-sputtered SiO2 protective coating.  
Microparticle-cell interaction studies at stationary and flow conditions 
For the interaction studies the BSA-MP and WGA-MP were suspended in isotonic 20 mM 
HEPES/NaOH pH 7.4 at a concentration of 7.5 x 105 particles per 500 µL. Shortly before the 
experiment, the cell culture medium was removed from the 3D-microchannels and the 
monolayers were washed once with isotonic 20 mM HEPES/NaOH pH 7.4 (500 µL). 
Subsequently, the microparticle suspension was added and the channels were covered with a 
glass cover slip. In order to grant efficient transmission of the SAWs, 50 µL of water were 
pipetted on the piezoelectric chip as a coupling fluid before the 3D-microchannel was placed 
on top of it. This setup was mounted on a fluorescence microscope and connected to the high 
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frequency generator, which had been configured to supply preset energy inputs corresponding 
to flow velocities of 0 µm s-1, 300 µm s-1, 800 µm s-1, 1200 µm s-1 and 1700 µm s-1 
respectively. Following incubation at either stationary or flow conditions for 30 min, the 
monolayers were washed three times with isotonic 20 mM HEPES/NaOH pH 7.4 (500 µL) 
and embedded as described below. For an alternative set of experiments, monolayers loaded 
for 30 min under stationary conditions were washed and subsequently subjected to stationary 
or flow chase-incubation. After two additional washing steps with isotonic 20 mM 
HEPES/NaOH (500 µL) the PDMS-structure was peeled off these channels as well. The glass 
cover slips with the adherent monolayers were embedded in a drop of FluorSaveTM 
(Calbiochem®, USA and Canada) and were stored at 4°C for 12 hours prior to further 
analyses. 
Fluorescence microscopy and software-based analysis 
The embedded Caco-2 monolayers were analysed on a Nikon Eclipse 50i microscope (Nikon 
Corp., Japan) equipped with an EXFO X-Cite 120 fluorescence illumination system. A 
random series of non-overlapping fluorescence microscopic images (n = 6) was acquired over 
the channel area, whereby care was taken to analyze monolayer parts located in the centre of 
the 3D-microchannels. To grant comparability, the settings of the fluorescence lamp and 
exposure time were left constant during the data acquisition process. Finally, the number of 
cell-associated microparticles in every image was determined with the threshold-dependant 
automated particle analysis of ImageJ (NIH, USA). The number of cell-associated particles 
represents the mean value which was calculated from the images acquired in independent 
channels (n = 2). 
Antibody staining 
After incubation at stationary and flow conditions respectively, the monolayers were fixed 
with a 2% solution of paraformaldehyde for 15 min at room temperature and were washed 
with phosphate buffered saline pH 7.4 (PBS; 500 µL). Upon treatment with a 50 mM solution 
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of NH4Cl for 15 min and with a 0.1% solution of Triton X-100 for 10 min, the cells were 
washed again with PBS (500 µL). The tight junction associated protein ZO-1 was stained for 
1 h at 37°C with a primary antibody (BD Biosciences, San Jose, USA) diluted 1:100 in a 1% 
solution of BSA in PBS. Upon washing thrice with a 1% solution of BSA in PBS, the 
monolayers were incubated with a 1:100 dilution of a secondary Anti-Mouse 
Immunoglobulin-RPE antibody (Dako Denmark A/S, Glostrup, Denmark) for 30 min at 37°C. 
Finally, the cell layer was washed three times with a 1% solution of BSA in PBS and mounted 
in a drop of FluorSaveTM.  
 
Conclusion 
Stationary binding assays have become the current standard in preclinical biopharmaceutical 
testing due to the rather simple handling and lack of alternative in vitro models. To approach 
this shortcoming, an acoustically-driven thumbnail-sized microfluidic chip was developed 
that can controllably and reproducibly generate flow in 3D-microchannels which are 
compatible with cell culture. This SAW-chip was used to investigate the binding properties of 
albumin- and wheat germ agglutinin-conjugated microparticles to an epithelial cell layer 
under flow conditions. As illustrated in the present work, the results obtained from binding 
assays under stationary conditions notably differ from those obtained in systems simulating 
the dynamic in vivo environment. It was found that non-targeted microparticles possess a very 
low propensity to bind and are detached in the presence of flow, while conjugation with WGA 
led to a distinctly improved adhesion of particles to the cell-layer at shear rates ranging from 
0.2 s-1 to 1 s-1. In conclusion, these results clearly underline the importance of surface 
functionalization for the design of nano- and microparticulate drug delivery vehicles. 
Elaborate models of the in vivo conditions are necessary in order to realistically predict and 
optimize the performance of such systems prior to animal studies. In this context, the 
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developed microfluidic SAW-chip is expected to provide a highly versatile platform for an 
investigation of flow-associated effects on particle-cell adhesion processes. Fundamental 
information distilled from studies using this technology will deeply benefit the engineering of 
artificial drug carrier systems which perform with high efficiency in the dynamically complex 
physiological environment.  
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